These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2842159)

  • 1. Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptide.
    Bork E; Hansen M; Urdal P; Paus E; Holst JJ; Schifter S; Fenger M; Engbaek F
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1033-8. PubMed ID: 2842159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant monitoring of serum neuron-specific enolase and creatine kinase BB in small cell lung cancer.
    Liippo KK; Terho T
    Acta Oncol; 1991; 30(3):321-4. PubMed ID: 1645171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.
    Niho S; Nishiwaki Y; Goto K; Ohmatsu H; Matsumoto T; Hojo F; Ohe Y; Kakinuma R; Kodama T
    Lung Cancer; 2000 Mar; 27(3):159-67. PubMed ID: 10699689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined measurements of neuron specific enolase and bombesin/gastrin releasing peptide in lung cancer.
    Scagliotti GV; Piani M; Gatti E; Gozzelino F; Albera C; Pozzi E
    Eur Respir J; 1989 Sep; 2(8):746-50. PubMed ID: 2553476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer.
    Ariyoshi Y; Kato K; Ueda R; Takahashi T; Sato T; Akatsuka H; Kuwabara M; Kito K; Suchi T; Nishimura M
    Jpn J Clin Oncol; 1986 Sep; 16(3):213-21. PubMed ID: 3022031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer.
    Jaques G; Bepler G; Holle R; Wolf M; Hannich T; Gropp C; Havemann K
    Cancer; 1988 Jul; 62(1):125-34. PubMed ID: 2838147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer].
    Zhou J; Xiong Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):90-3. PubMed ID: 7657349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J
    Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor markers in patients with lung cancer.
    Hansen M; Pedersen AG
    Chest; 1986 Apr; 89(4 Suppl):219S-224S. PubMed ID: 3007040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma, compared with neuron-specific enolase].
    Maruno K
    Nihon Geka Gakkai Zasshi; 1990 Jun; 91(6):760-5. PubMed ID: 2169019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer.
    Sunaga N; Tsuchiya S; Minato K; Watanabe S; Fueki N; Hoshino H; Makimoto T; Ishihara S; Saito R; Mori M
    Oncology; 1999; 57(2):143-8. PubMed ID: 10461062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
    Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
    Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating arginine-vasopressin, calcitonin, carcinoembryonic antigen, neuron-specific enolase, and beta-2 microglobulin fluctuations during combined modality induction therapy for small-cell bronchogenic carcinoma. Association of postchemotherapy AVP surge with high tumor response rate and durable remission.
    Biran H; Feld R; Malkin A
    Tumour Biol; 1991; 12(3):131-7. PubMed ID: 1648782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
    Okusaka T; Eguchi K; Kasai T; Kurata T; Yamamoto N; Ohe Y; Tamura T; Shinkai T; Saijo N
    Clin Cancer Res; 1997 Jan; 3(1):123-7. PubMed ID: 9815547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.
    Batandier C; Brambilla E; Nagy-Mignotte H; Laporte F; Jacrot M; Beriel H; Paramelle B; Brambilla C
    Scand J Clin Lab Invest; 1989 Feb; 49(1):33-42. PubMed ID: 2543057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
    Spinazzi A; Soresi E; Boffi R; Nonis A; Noseda A; Cobelli S; Scanni A
    Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-specific enolase, thymidine kinase, and tissue polypeptide-specific antigen in diagnosis and response to chemotherapy of small-cell lung cancer.
    Abbasciano V; Sartori S; Trevisani L; Nielsen I; Ferrazzi E; Bononi A; Toso S; Crepaldi G; Bianchi MP; Gilli G; Zavagli G
    Cancer Detect Prev; 1999; 23(4):309-15. PubMed ID: 10403902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
    Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
    Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
    Nisman B; Heching N; Biran H; Barak V; Peretz T
    Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.